West Pharmaceutical Services Inc (NYSE:WST) over-valued by 11%
| Website | https://www.westpharma.com/ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Fiscal Year End | Dec 31, 2020 |
| Market Cap | $22,159,521,792 |
| Beta | 1.13514 |
| Average Volume | $470,103 |
| Last Dividend | 0.83% |
| Price on Feb 23, 2021 | $296.52 |
| Autochartist™ Valuation | $265.20 |
| Conclusion |
11% over-valued |
| Download Report |
